Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hodolar: Ondansetron for LARS
NCT03182179Completed
- Sponsor
- Ente Ospedaliero Cantonale
- Start
- Nov 2016
- Primary completion
- Nov 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of ondansetron in low anterior resection syndrome (LARS) (2 arms), sponsored by Ente Ospedaliero Cantonale. Primary endpoint: Change in Low Anterior Resection Syndrome Score at 10 weeks. Started Nov 2016; status: completed.
02
Drugs
ondansetron
03
Conditions
low anterior resection syndrome (LARS)
Beyond the preview
Go deeper on NCT03182179.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03182179.